Kulika Weizman is a principal at Creative Ventures. She leverages her operational experience as a synbio co-founder & CEO and her scientific expertise to lead investments in early-stage deep tech companies solving humanity’s most critical crises:  rising healthcare costs, climate change, and labor shortages.